期刊文献+

健脾利水方配合腹腔灌注化疗治疗恶性腹水40例临床研究 被引量:6

Clinical Study on 40 Cases of Malignant Ascites Treated by Jianpi Lishui Recipe Combined with Intraperitoneal Chemotherapy
下载PDF
导出
摘要 目的观察自拟健脾利水方治疗恶性腹腔积液患者的疗效。方法选取自2013年4月至2015年4月于大连市中医医院肿瘤科收治的恶性腹腔积液病例40例,采用信封法随机分为试验组和对照组,对照组20例,采用常规治疗恶性腹腔积液的方法,试验组20例,在对照组的基础上采用口服中药健脾利水方,观察患者临床疗效。结果试验组优于对照组,有统计学差异(P<0.05)。结论健脾利水方治疗恶性腹腔积液疗效肯定。 Objective To observe the effect of Jianpi Lishui Decoction in treatment of patients with malignant peritoneal effusion. Methods From April April 2013 to 2015 in Dalian City Hospital of traditional Chinese medicine were malignant peritoneal effusion were 40 cases. The envelopes were randomly divided into experimental group and control group, 20 cases in the control group, using conventional treatment of malignant peritoneal effusion method. The experimental group 20 cases, when uses according to group on the basis of the traditional Chinese medicine oral spleen and water, observe clinical efficacy. Results The experimental group was better than the control group, with statistical difference(P <0.05). Conclusion The curative effect of the treatment of malignant peritoneal effusion is positive.
作者 毕磊
出处 《中国医药指南》 2017年第18期26-26,28,共2页 Guide of China Medicine
关键词 健脾利水方 中药 恶性腹腔积液 The decoction of invigorating the spleen and the spleen Chinese traditional medicine Malignant ascites
  • 相关文献

参考文献4

二级参考文献38

  • 1李德,许德顺,王化洲,等.腹腔肿瘤的化疗与免疫治疗[M].北京:人民卫生出版社,1990:59-63.
  • 2D' Amieo T A. Angiogenesis in non-small cell lung cancer[J]. Semin Thorac C, ardiovasc Surg, 2004,16 ( 1 ) : 13-18.
  • 3Schneider M,Tjwa M,Carmeliet P. A surrogate marker to monitor angiogenesis at last[J]. Cancer Cell, 2005,7 (1): 3-4.
  • 4Beerepoot L V, Mehra N, Vermaat J S, et al. Increased levels of viable circulating endothelial cells are indicator of progressive disease in cancer patients[J]. Ann Oncol, 2004,15 (1) : 139-145.
  • 5Roodhart J M,Langenherg M H,Vermaat J S,et al. Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients[J]. Neoplasia, 2010,12 (1) : 87 -94.
  • 6Yuan A,Yang P C,Yu C J, et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer [J]. Am J Respir Crit Care Med,1995, 152(6 Pt 1) :2157-2162.
  • 7Koukourakis M I,Giatromanolaki A,Thorpe P E, et al. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer[J]. Cancer Res, 2000,60 ( 11 ) : 3088-3095.
  • 8Bono P,Teerenhovi L,Joensuu H,et al. Elevated serum endostatin is associated with poor outcome in patients with non-hodgkin lymphoma[J]. Cancer, 2003,97 (11) : 2767-2775.
  • 9Bertolini F,Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification[J]. Nat Rev Cancer, 2006,6 ( 11 ): 835-845.
  • 10Mariucci S, Rovati B,Chatzileontiadou S, et al. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells[J]. Stand J Clin Lab Invest,2009,69(3) :433-438.

共引文献44

同被引文献90

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部